
    
      The total duration of observation per participant is 56-63 days from surgery broken down as
      follows:

        -  7 to 10-day initial treatment period with open-label Semuloparin sodium;

        -  Randomization;

        -  19 to 23-day double-blind treatment period with Semuloparin sodium or placebo;

        -  30-day follow-up period.

      Mandatory bilateral venography of the lower limbs is to be performed between 19 and 24 days
      after randomization.
    
  